TBC1D25 alleviates nonalcoholic steatohepatitis by inhibiting abnormal lipid accumulation and inflammation

被引:2
作者
Wu, Anding [1 ]
Ye, Mao [2 ]
Ma, Tengfei [3 ]
She, Zhigang [4 ]
Li, Ruyan [4 ]
Shi, Hongjie [5 ]
Yang, Ling [5 ]
Yi, Maolin [6 ]
Li, Huoping [2 ]
机构
[1] Huanggang Cent Hosp, Dept Gen Surg, Huanggang, Peoples R China
[2] HuangGang Cent Hosp, Dept Cardiol, Huanggang, Peoples R China
[3] Huanggang Cent Hosp, Dept Neurol, Huanggang, Peoples R China
[4] Renmin Hosp Wuhan Univ, Dept Cardiol, Wuhan, Peoples R China
[5] Huanggang Inst Translat Med, Huanggang, Peoples R China
[6] Huanggang Cent Hosp, Surg Mammary Gland & Thyroid Gland, Huanggang, Peoples R China
关键词
fibrosis; hepatic steatosis; inflammation; NASH; TAK1; FATTY LIVER-DISEASE; ACTIVATION; MODELS;
D O I
10.1002/jcp.30934
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is a strong stimulant of cardiovascular diseases, affecting one-quarter of the world's population. TBC1 domain family member 25 (TBC1D25) regulates the development of myocardial hypertrophy and cerebral ischemia-reperfusion injury; however, its effect on NAFLD/nonalcoholic steatohepatitis (NASH) has not been reported. In this study, we demonstrated that TBC1D25 expression is upregulated in NASH. TBC1D25 deficiency aggravated hepatic steatosis, inflammation, and fibrosis in NASH. In vitro tests revealed that TBC1D25 overexpression restrained NASH responses. Subsequent mechanistic validation experiments demonstrated that TBC1D25 interfered with NASH progression by inhibiting abnormal lipid accumulation and inflammation. TBC1D25 deficiency significantly promoted NASH occurrence and development. Therefore, TBC1D25 may potentially be used as a clinical therapeutic target for NASH treatment.
引用
收藏
页码:393 / 406
页数:14
相关论文
共 36 条
[1]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[2]   TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer [J].
Chen, Min ;
Sheng, Xiu-Jie ;
Qin, Yuan-Yi ;
Zhu, Song ;
Wu, Qing-Xia ;
Jia, Liqing ;
Meng, Nan ;
He, Yu-Tian ;
Yan, Guang-Rong .
THERANOSTICS, 2019, 9 (03) :676-690
[3]   Nonalcoholic Fatty Liver Disease An Emerging Driver of Cardiac Arrhythmia [J].
Chen, Ze ;
Liu, Jiayi ;
Zhou, Feng ;
Li, Haomiao ;
Zhang, Xiao-Jing ;
She, Zhi-Gang ;
Lu, Zhibing ;
Cai, Jingjing ;
Li, Hongliang .
CIRCULATION RESEARCH, 2021, 128 (11) :1747-1765
[4]   Tbc1d1 deletion suppresses obesity in leptin-deficient mice [J].
Dokas, J. ;
Chadt, A. ;
Joost, H-G ;
Al-Hasani, H. .
INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (08) :1242-1249
[5]   Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 [J].
Estes, Chris ;
Anstee, Quentin M. ;
Teresa Arias-Loste, Maria ;
Bantel, Heike ;
Bellentani, Stefano ;
Caballeria, Joan ;
Colombo, Massimo ;
Craxi, Antonio ;
Crespo, Javier ;
Day, Christopher P. ;
Eguchi, Yuichiro ;
Geier, Andreas ;
Kondili, Loreta A. ;
Kroy, Daniela C. ;
Lazarus, Jeffrey V. ;
Loomba, Rohit ;
Manns, Michael P. ;
Marchesini, Giulio ;
Nakajima, Atsushi ;
Negro, Francesco ;
Petta, Salvatore ;
Ratziu, Vlad ;
Romero-Gomez, Manuel ;
Sanyal, Arun ;
Schattenberg, Joern M. ;
Tacke, Frank ;
Tanaka, Junko ;
Trautwein, Christian ;
Wei, Lai ;
Zeuzem, Stefan ;
Razavi, Homie .
JOURNAL OF HEPATOLOGY, 2018, 69 (04) :896-904
[6]   The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons [J].
Finelli, Mattea J. ;
Aprile, Davide ;
Castroflorio, Enrico ;
Jeans, Alexander ;
Moschetta, Matteo ;
Chessum, Lauren ;
Degiacomi, Matteo T. ;
Grasegger, Julia ;
Lupien-Meilleur, Alexis ;
Bassett, Andrew ;
Rossignol, Elsa ;
Campeau, Philippe M. ;
Bowl, Michael R. ;
Benfenati, Fabio ;
Fassio, Anna ;
Oliver, Peter L. .
HUMAN MOLECULAR GENETICS, 2019, 28 (04) :584-597
[7]   Illuminating the functional and structural repertoire of human TBC/ RABGAPs [J].
Frasa, Marieke A. M. ;
Koessmeier, Katja T. ;
Ahmadian, M. Reza ;
Braga, Vania M. M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (02) :67-73
[8]   Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum [J].
Hardy, Timothy ;
Oakley, Fiona ;
Anstee, Quentin M. ;
Day, Christopher P. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :451-496
[9]   Biallelic loss-of-function variants in TBC1D2B cause a neurodevelopmental disorder with seizures and gingival overgrowth [J].
Harms, Frederike L. ;
Parthasarathy, Padmini ;
Zorndt, Dennis ;
Alawi, Malik ;
Fuchs, Sigrid ;
Halliday, Benjamin J. ;
McKeown, Colina ;
Sampaio, Hugo ;
Radhakrishnan, Natasha ;
Radhakrishnan, Suresh K. ;
Gorce, Magali ;
Navet, Benjamin ;
Ziegler, Alban ;
Sachdev, Rani ;
Robertson, Stephen P. ;
Nampoothiri, Sheela ;
Kutsche, Kerstin .
HUMAN MUTATION, 2020, 41 (09) :1645-1661
[10]   Differing susceptibility to autophagic degradation of two LC3-binding proteins: SQSTM1/p62 and TBC1D25/OATL1 [J].
Hirano, Satoshi ;
Uemura, Takefumi ;
Annoh, Hiromichi ;
Fujita, Naonobu ;
Waguri, Satoshi ;
Itoh, Takashi ;
Fukuda, Mitsunori .
AUTOPHAGY, 2016, 12 (02) :312-326